Patents by Inventor Ljiljana Palangetic

Ljiljana Palangetic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240041780
    Abstract: The present invention discloses a sealing fluid comprising an organic acid, an alcohol and optionally water, the organic acid is lactic acid or acetic acid, the alcohol is isopropanol or ethanol, the sealing fluid is a liquid composition for sealing telescopically joined hard capsules with coaxial partly overlapping body parts.
    Type: Application
    Filed: December 13, 2021
    Publication date: February 8, 2024
    Applicant: CAPSUGEL BELGIUM NV
    Inventors: Stephanie Laurichesse, Ljiljana Palangetic
  • Patent number: 11890383
    Abstract: The present invention provides ingestible dosage form articles such as opaque capsules with reduced light transmittance.
    Type: Grant
    Filed: November 1, 2022
    Date of Patent: February 6, 2024
    Assignee: Capsugel Belgium NV
    Inventors: Ljiljana Palangetic, Delphine Nombret, Stefaan Jaak Vanquickenborne
  • Publication number: 20230414524
    Abstract: The invention discloses double layered delayed-release hard capsules made by double dipping, that is by two consecutive dip molding steps on the same mold pin without removing the film, provided by the first dip molding step, from the mold pin between the two dip molding steps, but dipping the mold pin with this first film in the second dip molding step, each dip molding step is done with a different polymer melt, providing a double layered delayed-release capsule.
    Type: Application
    Filed: November 25, 2021
    Publication date: December 28, 2023
    Applicant: Capsugel Belgium NV
    Inventors: Xiongwei He, Ljiljana Palangetic, Stefaan Vanquickenborne, Jerome Cuevas
  • Publication number: 20230165802
    Abstract: The invention discloses hydroxypropyl methylcellulose (HPMC) capsules containing a small amount of CaCl2, which show reduced powder retention when used in Dry Powder Inhalers (DPI), and a method for making them.
    Type: Application
    Filed: April 20, 2021
    Publication date: June 1, 2023
    Inventors: Ivana Staka, Jonathan Cape, Ljiljana Palangetic, Stefaan Vanquickenborne
  • Publication number: 20230090812
    Abstract: The present invention provides ingestible dosage form articles such as opaque capsules with reduced light transmittance.
    Type: Application
    Filed: November 1, 2022
    Publication date: March 23, 2023
    Applicant: Capsugel Belgium NV
    Inventors: Ljiljana Palangetic, Delphine Nombret, Stefaan Jaak Vanquickenborne
  • Patent number: 11517535
    Abstract: The present invention provides ingestible dosage form articles such as opaque capsules with reduced light transmittance.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: December 6, 2022
    Assignee: Capsugel Belgium NV
    Inventors: Ljiljana Palangetic, Delphine Nombret, Stefaan Jaak Vanquickenborne
  • Publication number: 20220347106
    Abstract: The invention discloses opaque capsule shells made from gelatin with ground CaCO3 as opacifier; and a method for making them.
    Type: Application
    Filed: October 8, 2020
    Publication date: November 3, 2022
    Inventors: Stephanie LAURICHESSE, Ljiljana PALANGETIC, Stefaan VANQUICKENBORNE
  • Publication number: 20210052505
    Abstract: The present invention provides ingestible dosage form articles such as opaque capsules with reduced light transmittance.
    Type: Application
    Filed: May 14, 2019
    Publication date: February 25, 2021
    Inventors: Ljiljana Palangetic, Delphine Nombret, Stefaan Jaak Vanquickenborne